Clinical outcomes and treatment patterns in REASSURE: planned interim analysis of a real-world observational study of radium-223 in metastatic castration-resistant prostate cancer
eClinicalMedicine(2023)
Abstract
Bayer HealthCare.
MoreTranslated text
Key words
Clinical outcomes,Radium-223,Metastatic castration-resistant prostate cancer
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined